| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 2,022 | $18.72 | $37,856.29 | -1.2% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Maney Rochelle L. | VP, Quality | Sell | 1,157 | $18.72 | $21,661.82 | -2.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 1,160 | $18.72 | $21,717.64 | -2.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 1,506 | $18.72 | $28,195.48 | -1.7% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,152 | $18.72 | $21,568.09 | -0.8% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 13,996 | $18.72 | $262,037.31 | -1.9% | +26.6% | +36.5% | |
| Mar 4, 2024 | MMSI Merit Medical Systems Inc | Gunderson Thomas James | Director | Sell | 18,157 | $76.03 | $1,380,513.02 | -48.5% | +7.4% | +33.2% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Turakhia Minang46 | EVP, CMO &CSO | Sell | 943 | $111.14 | $104,805.02 | -3.2% | -22.9% | -1.6% | |
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 5,275 | $4.87 | $25,694.53 | -0.7% | -61.7% | -72.3% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | Cbo And CLO | Sell | 1,525 | $111.14 | $169,488.50 | -3.1% | -22.9% | -1.6% | |
| Mar 4, 2024 | PRCT Procept Biorobotics Corp | Krummel Thomas M69 | Director | Sell | 20,000 | $48.53 | $970,642.70 | -12.5% | +37.0% | +35.8% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Patterson Chad57 | Chief Commercial Officer | Sell | 1,077 | $111.14 | $119,697.78 | -2.6% | -22.9% | -1.6% | |
| Mar 4, 2024 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 13,603 | $107.19 | $1,458,090.45 | -66.2% | +3.4% | +31.8% | |
| Mar 4, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 7,535 | $0.37 | $2,793.98 | -1.4% | -9.8% | -7.2% | |
| Mar 4, 2024 | AHCO Adapthealth Corp. | Prast Albert A. | Chief Technology Officer | Sell | 135,443 | $10.41 | $1,409,961.63 | -42.8% | -9.5% | -2.3% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.62 | EVP, Corp Dev Inv Rel | Sell | 2,452 | $111.14 | $272,515.28 | -7.4% | -22.9% | -1.6% | |
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 9,186 | $4.87 | $44,745.01 | -0.5% | -61.7% | -72.3% | |
| Mar 4, 2024 | DXR Daxor Corp | Feuer Edward | Director | Buy | 1,000 | $7.21 | $7,210.00 | New | +21.8% | +4.9% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Bobzien Brice49 | Chief Financial Officer | Sell | 1,401 | $111.14 | $155,707.14 | -5.2% | -22.9% | -1.6% | |
| Mar 4, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 8,273 | $0.37 | $3,069.28 | -0.7% | -9.8% | -7.2% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.60 | President And CEO | Sell | 4,221 | $111.14 | $469,121.94 | -2.3% | -22.9% | -1.6% | |
| Mar 4, 2024 | MMSI Merit Medical Systems Inc | Evans Stephen C.64 | Director | Sell | 1,000 | $76.35 | $76,348.00 | -12.2% | +7.4% | +33.2% | |
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 2,968 | $4.87 | $14,457.13 | -1.3% | -61.7% | -72.3% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Shrishrimal Sumi60 | EVP, Chief Risk Officer | Sell | 723 | $111.14 | $80,354.22 | -2.9% | -22.9% | -1.6% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Day Mark J.57 | Chief Technology Officer | Sell | 3,248 | $111.14 | $360,982.72 | -5.0% | -22.9% | -1.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.